OpenURL Connection Search

Select item for more details and to access through your institution.

Management of Atopy with Dupilumab and Omalizumab in CADINS Disease.
Published in:
Journal of Clinical Immunology, 2024, v. 44, n. 2, p. 1, doi. 10.1007/s10875-023-01636-y
By:
- Diaz-Cabrera, Natalie M.;
- Bauman, Bradly M.;
- Iro, Mildred A.;
- Dabbah-Krancher, Gina;
- Molho-Pessach, Vered;
- Zlotogorski, Abraham;
- Shamriz, Oded;
- Dinur-Schejter, Yael;
- Sharon, Tatyana Dubnikov;
- Stepensky, Polina;
- Tal, Yuval;
- Eisenstein, Eli M.;
- Pietzsch, Leonora;
- Schuetz, Catharina;
- Abreu, Damien;
- Coughlin, Carrie C.;
- Cooper, Megan A.;
- Milner, Joshua D.;
- Williams, Anthony;
- Armoni-Weiss, Gil
Publication type:
Article
Pancreatic stone protein/regenerating protein is a potential biomarker for endoplasmic reticulum stress in beta cells.
Published in:
Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-41604-4
By:
- Stone, Stephen;
- Abreu, Damien;
- Mahadevan, Jana;
- Asada, Rie;
- Kries, Kelly;
- Graf, Rolf;
- Marshall, Bess A.;
- Hershey, Tamara;
- Urano, Fumihiko
Publication type:
Article
10. Dantrolene as a Therapeutic Option for Wolfram Syndrome (134-OR).
Published in:
Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 63, doi. 10.1007/s12467-015-0031-z
By:
- Urano, Fumihiko;
- Lu, Simin;
- Mahadevan, Jana;
- Abreu, Damien;
- Kanekura, Kohsuke
Publication type:
Article
85-LB: A Phase 1b/2 Clinical Trial of Dantrolene Sodium in Patients with Wolfram Syndrome.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-85-LB
By:
- ABREU, DAMIEN;
- PEARSON, TONI S.;
- BUCELLI, ROBERT C.;
- SIMPSON, ASHLEY;
- BROWN, CRIS M.;
- KRIES, KELLY;
- GU, HONGJIE;
- STONE, STEPHEN I.;
- TYCHSEN, LAWRENCE;
- STAVERN, GREGORY VAN;
- WHITE, NEIL H.;
- MARSHALL, BESS A.;
- HERSHEY, TAMARA;
- URANO, FUMIHIKO
Publication type:
Article
345-LB: Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF): A New Therapeutic Target for Wolfram Syndrome.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-345-LB
By:
- MORIKAWA, SHUNTARO;
- MAHADEVAN, JANA;
- YAGI, TAKUYA;
- ABREU, DAMIEN;
- KANEKURA, KOHSUKE;
- BROWN, CRIS M.;
- URANO, FUMIHIKO
Publication type:
Article
Dominant ER Stress-Inducing Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts.
Published in:
2017
By:
- De Franco, Elisa;
- Flanagan, Sarah E.;
- Takuya Yagi;
- Abreu, Damien;
- Mahadevan, Jana;
- Johnson, Matthew B.;
- Jones, Garan;
- Acosta, Fernanda;
- Mulaudzi, Mphele;
- Ngee Lek;
- Oh, Vera;
- Petz, Oliver;
- Caswell, Richard;
- Ellard, Sian;
- Fumihiko Urano;
- Hattersley, Andrew T.;
- Yagi, Takuya;
- Lek, Ngee;
- Urano, Fumihiko
Publication type:
journal article

Found: 6

Management of Atopy with Dupilumab and Omalizumab in CADINS Disease.

Pancreatic stone protein/regenerating protein is a potential biomarker for endoplasmic reticulum stress in beta cells.

10. Dantrolene as a Therapeutic Option for Wolfram Syndrome (134-OR).

85-LB: A Phase 1b/2 Clinical Trial of Dantrolene Sodium in Patients with Wolfram Syndrome.

345-LB: Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF): A New Therapeutic Target for Wolfram Syndrome.

Dominant ER Stress-Inducing Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts.